TrialCell reports. Medicine2022
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.
Konstantinos Leventogiannis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
102 papers cite itlatest 60 shown
this paperpooled itcites it